Human/Viral gene | Oligo | Sequence (5'−3') | Final conc. (nM) | Reference |
---|---|---|---|---|
18S rRNA | FW | CGCCGCTAGAGGTGAAATTC | 500 | [39] |
 | RV | GGCAAATGCTTTCGCTCTG | 500 |  |
 | P | FAM-TGGACCGGCGCAAGACGGA-BHQ | 125 |  |
B2M | FW | CTCCGTGGCCTTAGCTGTG | 1000 | [33] |
 | RV | TTTGGAGTACGCTGGATAGCCT | 1000 |  |
IFN-β | FW | CGCCGCATTGACCATCTA | 300 | [38] |
 | RV | TTAGCCAGGAGGTTCTCAACAATAGTGTCA | 900 |  |
 | P | FAM-TCAGACAAGATTCATCTAGCACTGGCTGGA-BHQ1 | 100 |  |
IFN-λ1/IL-29 | FW | GGACGCCTTGGAAGAGTCACT | 300 | [46] |
 | RV | AGAAGCCTCAGGTCCCAATTC | 900 |  |
 | P | FAM-AGTTGCAGCTCTCCTGTCTTCCCCG-BHQ1 | 100 |  |
IFN-λ2/3/IL-28 | FW | CTGCCACATAGCCCAGTTCA | 300 | [46] |
 | RV | AGAAGCGACTCTTCTAAGGCATCTT | 900 |  |
 | P | FAM-TCTCCACAGGAGCTGCAGGCCTTTA-BHQ1 | 100 |  |
IP10/CXCL10 | FW | CCATTCTGATTTGCTGCCTTATC | 900 | [40] |
 | RV | GCAGGTACAGCGTACAGTTCT | 900 |  |
 | P | FAM-CTGACTCTAAGTGGCATTCAAGGAGTACCTCTCTC-TAMRA | 100 |  |
IL-6 | FW | CCAGGAGCCCAGCTATGAAC | 300 | [41] |
 | RV | CCCAGGGAGAAGGCAACTG | 900 |  |
 | P | FAM-CCTTCTCCACAAGCGCCTTCGGT-TAMRA | 100 |  |
ACE2 | FW | CATTGGAGCAAGTGTTGGATCTT | 1000 | [44] |
 | RV | GAGCTAATGCATGCCATTCTCA | 1000 |  |
 | P | FAM-CTTGCAGCTACACCAGTTCCCAGGCA-MGBQ500 | 125 |  |
TMPRSS2 | FW | Sequence information not given by the manufacturer | Â | Applied biosystems, TaqMan gene expression assay |
 | RV |  |  | Hs01122322_m1 |
 | P |  |  |  |
SARS-CoV-2 E Sarbeco | FW | ACAGGTACGTTAATAGTTAATAGCGT | 400 | Adapted from [42] |
 | RV | ATATTGCAGCAGTACGCACACA | 600 |  |
 | P1 | FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ | 125 |  |
Flu panAmod | FW | AGATGAGYCTTCTAACCGA | 500 | [43] |
 | RV | GCAAAGACATCTTCAAGTYTC | 250 |  |
 | P | FAM-TCAGGCCCCCTCAAAGCCGA-BHQ1 | 250 |  |
Flu M swine | RV | GCAAAGACACYTTCCAGTCTC | 250 | [43] |
CDK2NA (p16) | FW | TGAGCTTTGGTTCTGCCATT | 1000 | [47] |
 | RV | AGCTGTCGACTTCATGAC AAG | 1000 |  |